ZURICH, Sept 2 (Reuters) – Novartis could cut about 130 jobs in Switzerland as it relocates laboratory activities and shuts down some production in Basel, the Swiss drugmaker said on Wednesday. The company said it plans to transfer laboratories for biological cell banks, analytical testing procedure
Leading U.S. medical groups are urging people to get updated flu and COVID-19 vaccinations this fall, banding together Wednesday to issue shot guidelines — and highlight the science behind them — saying they hope to ease confusion caused by the Trump administration’s changing advice. Flu vaccination
By Olivia Le Poidevin GENEVA, Sept 2 (Reuters) – The head of the World Health Organization on Wednesday said the Ebola response needs to be scaled up to tackle the outbreak in the Democratic Republic of Congo, with tracking the chains of transmission still posing a challenge. “Until every chain is f
By Gradel Muyisa and Ange Kasongo BENI, Democratic Republic of Congo, Sept 2 (Reuters) – Schools reopened this week in areas of Democratic Republic of Congo hardest hit by Ebola, after authorities decided the risk of transmission was outweighed by the risk of pupils struggling with remote learning,
Sept 2 (Reuters) – Dutch gene therapy developer uniQure said on Wednesday it had applied for U.S. approval of its experimental treatment for Huntington’s disease after the FDA reversed its earlier position on the drug, sending the company’s shares up 5% in premarket trading. Huntington’s disease is
Sept 2 (Reuters) – South Korea’s Alteogen said on Wednesday it has signed a deal with Novartis worth up to $3.22 billion, giving the Swiss drugmaker access to its technology to make injectable versions of intravenous drugs. Here are the details: • Drugmakers are increasingly developing under-the-ski
Sept 2 (Reuters) – Bayer said on Wednesday its Crop Science business had introduced two out of 10 planned new products with peak annual sales of at least €500 million ($579 million) each and mapped out further market launches. Holding an investor event for the division, the German group also said it
By Sahil Pandey Sept 2 (Reuters) – AI company Owkin said on Wednesday it has signed a licensing deal with Germany’s Boehringer Ingelheim, giving the drugmaker access to its AI research platform and patient data to speed up discovery of drugs for cancer and immunity-related diseases. The deal adds Bo
Sept 2 (Reuters) – Israeli drugmaker Teva Pharmaceutical Industries, said on Wednesday its experimental drug helped prevent gluten-related intestinal damage in adults with celiac disease, meeting the main goal of a mid-stage trial. U.S.-listed shares of the company were up nearly 3% in early trading
DUBLIN, Sept 2 (Reuters) – Ireland’s health service operator was fined a record amount for an Irish public body by the country’s data regulator for storing medical records in “profound disarray” in areas including a turf shed and a disused bathroom that in some cases were contaminated by animal drop
By Nqobile Dludla JOHANNESBURG, Sept 2 (Reuters) – South Africa’s Aspen Pharmacare reported a 22% rise in annual normalised earnings on Wednesday, helped by strong demand for obesity and diabetes treatment Mounjaro, which it distributes, and improving profitability in its manufacturing business. The
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid Sept 2 (Reuters) – We also report on a study that may have found a way to prevent liver damage caused by fatty liver diseases, which affect millions of people. GENET
DAKAR, Sept 2 (Reuters) – The number of deaths in Democratic Republic of Congo’s Ebola outbreak has surpassed 3,000, government data showed on Wednesday, as the country’s worst-ever epidemic continues to spread across its northeast. The outbreak, caused by the Bundibugyo species of Ebola, became the
PLYMOUTH, Mass. (AP) — A Massachusetts jury plans to deliberate for a fifth day Wednesday on whether Lindsay Clancy was criminally responsible when she strangled her three children in 2023, amid conflicting testimony about her postpregnancy mental health. What happens if they can’t reach a verdict?
JAKARTA, Sept 2 (Reuters) – More than 500 students in Indonesia’s East Java were hospitalised with food poisoning suspected to have been caused by free meals provided by the government, and an investigation is underway, national and regional officials said on Wednesday. President Prabowo Subianto la
Sept 2 (Reuters) – Australia’s competition regulator on Wednesday approved Kimberly-Clark’s proposed $40 billion takeover of Kenvue, on condition the company divests Kenvue’s Carefree and Stayfree period care brands in the country to address competition concerns. Here are the details: • The Australi
WASHINGTON (AP) — The U.S. Department of Justice filed a federal lawsuit Tuesday against the school system in Kansas City, Kansas, over its policies on transgender students. The lawsuit comes more than a year after the Education Department first said it was investigating four districts in Kansas fol
Sept 1 (Reuters) – Britain said on Tuesday it would provide more than £50 million ($67.56 million) in new funding to support efforts to contain an Ebola outbreak in the Democratic Republic of Congo, where confirmed cases have surpassed 6,000 in the country’s largest-ever epidemic. • Britain allocate
By Dietrich Knauth NEW YORK, September 1 (Reuters) – A U.S. federal jury sided with Reckitt Benckiser’s Mead Johnson on Monday in a test trial over claims the company’s Enfamil infant formula for preterm babies caused necrotizing enterocolitis (NEC), a dangerous bowel disease. The Illinois jury conc
BUNIA, Congo (AP) — A new academic year began Tuesday across Congo despite concerns by parents and teachers that the ongoing Ebola outbreak poses risks to children in the epicenter. The resumption of classes comes in the middle of the fastest-growing outbreak of the disease ever, with 2,950 people k
Sept 1 (Reuters) – Alumis said on Tuesday it plans to advance its experimental drug for a type of immunity-related condition in a smaller subset of patients, even after the treatment failed to meet the main goal of a mid-stage trial. Its shares slumped more than 55% in premarket trading, as Wall Str
PARIS, Sept 1 (Reuters) – The European Union will suspend meat imports from Brazil from September 3 after the South American country failed to guarantee its compliance with EU rules on the use of antimicrobial substances, an EU Commission spokesperson said on Tuesday. • The EU had announced in May t
Sept 1 (Reuters) – Britain’s medicines regulator on Tuesday suspended the use and sale of Amgen’s rare-disease drug Tavneos to new patients, saying the main study supporting its approval was unreliable. Sold as Avacopan Vifor in Britain by CSL Vifor, the drug is used with other medicines to treat se
Sept 1 (Reuters) – Switzerland’s Roche will pay $75 million upfront to Simcere Pharmaceutical Group for rights to an experimental blood cancer drug, the Chinese drugmaker said Tuesday. • SIM0660 targets B-cell malignancies, Simcere said in a filing to the Hong Kong stock exchange. • B cells are a ty
By Puyaan Singh and Padmanabhan Ananthan Sept 1 (Reuters) – Medtronic raised its fiscal 2027 revenue growth outlook and the lower end of its profit forecast on Tuesday, banking on strong demand for its heart devices used in complex cardiovascular procedures. Medtech firms have been riding a wave of
Sept 1 (Reuters) – UnitedHealth’s insurance unit said on Tuesday that a broad range of conditions will no longer need prior approval, effective October 1, as it aims to eliminate prior authorization for 30% of healthcare services by the end of this year. Here are the details: • The reduction spans
By Francis Mascarenhas and Aditya Kalra MUMBAI, Sept 1 (Reuters) – Indian authorities have raided an illegal operation in Mumbai that faked expiry dates and nutritional information on original food products manufactured by PepsiCo, Nestle, Coca-Cola and Unilever so they could be exported to other co
COPENHAGEN, Sep 1 (Reuters) – Novo Nordisk has launched its Wegovy pill in Germany, a spokesperson for the Danish drugmaker said on Tuesday, with investors keenly focused on the oral weight-loss treatment in light of intensifying competition with U.S. rival Eli Lilly. Novo was first to bring a highl
By Bhanvi Satija LONDON, Sept 1 (Reuters) – Swiss drugmaker Novartis said on Tuesday its oral drug remibrutinib outperformed an older treatment in reducing relapses in patients with a form of multiple sclerosis, boosting hopes the medicine could become a blockbuster product. The trial results mark t
Sept 1 (Reuters) – AstraZeneca and China’s Hutchmed said on Tuesday that a late-stage trial of a combination of their cancer drugs Tagrisso and Orpathys significantly improved progression-free survival when given early for a type of lung cancer. Cancer therapies make up nearly half of AstraZeneca’s
